ANNX241220C2000
- 0.00
- 0.000.00%
Annexon Newsroom
Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)
Express News | Annexon Inc : JP Morgan Cuts Target Price to $9 From $11
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Express News | Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Express News | Cantor Fitzgerald Reiterates Overweight on Annexon
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Annexon Analyst Ratings
Annexon | 10-Q: Q3 2024 Earnings Report
Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential
Annexon | 8-K: Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
Annexon Reports Q3 EPS (25c), Consensus (27c)
Express News | Annexon: Topline Data Expected Second Half 2026
Express News | Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
Express News | Annexon Biosciences Q3 Income From Operations USD -39.442 Million
Express News | Annexon Biosciences Q3 Cash & Investments USD 340.1 Million
Express News | Annexon Biosciences Q3 Basic EPS USD -0.25
Press Release: Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
Annexon 3Q Loss/Shr 25c >ANNX